Lowe, M., Murray, L., Tyagi, A., Gorrie, G., Miller, S., & Dani, K. (2022). Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine. The Journal of Headache and Pain: Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache", 23(1), . https://doi.org/10.1186/s10194-022-01456-2
Chicago-referens (17:e uppl.)Lowe, Michael, Lesley Murray, Alok Tyagi, George Gorrie, Sarah Miller, och Krishna Dani. "Efficacy of Erenumab and Factors Predicting Response After 3 months in Treatment Resistant Chronic Migraine." The Journal of Headache and Pain: Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign Against Headache" 23, no. 1 (2022). https://doi.org/10.1186/s10194-022-01456-2.
MLA-referens (9:e uppl.)Lowe, Michael, et al. "Efficacy of Erenumab and Factors Predicting Response After 3 months in Treatment Resistant Chronic Migraine." The Journal of Headache and Pain: Official Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign Against Headache", vol. 23, no. 1, 2022, https://doi.org/10.1186/s10194-022-01456-2.
